Загрузка...
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
BACKGROUND: There are a lot of unmet needs in patients with triple-negative breast cancer (TNBC). Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPAR-α) agonist, has been used for decades to treat hypertriglyceridaemia and mixed dyslipidaemia. Recent studies show that it might have...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4015735/ https://ncbi.nlm.nih.gov/pubmed/24529079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-96 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|